Literature DB >> 28431214

Interferon-γ Released by Activated CD8+ T Lymphocytes Impairs the Calcium Resorption Potential of Osteoclasts in Calcified Human Aortic Valves.

Edit Nagy1, Yang Lei2, Eduardo Martínez-Martínez2, Simon C Body3, Florian Schlotter2, Michael Creager2, Alexander Assmann4, Kamal Khabbaz5, Peter Libby2, Göran K Hansson6, Elena Aikawa7.   

Abstract

In calcific aortic valve disease (CAVD), activated T lymphocytes localize with osteoclast regions; however, the functional consequences of this association remain unknown. We hypothesized that CD8+ T cells modulate calcification in CAVD. CAVD valves (n = 52) dissected into noncalcified and calcified portions were subjected to mRNA extraction, real-time quantitative PCR, enzyme-linked immunosorbent assay, and immunohistochemical analyses. Compared with noncalcified portions, calcified regions exhibited elevated transcripts for CD8, interferon (IFN)-γ, CXCL9, Perforin 1, Granzyme B, and heat shock protein 60. Osteoclast-associated receptor activator of NK-κB ligand (RANKL), tartrate-resistant acid phosphatase (TRAP), and osteoclast-associated receptor increased significantly. The stimulation of tissue with phorbol-12-myristate-13-acetate and ionomycin, recapitulating CAVD microenvironment, resulted in IFN-γ release. Real-time quantitative PCR detected mRNAs for CD8+ T-cell activation (Perforin 1, Granzyme B). In stimulated versus unstimulated organoid cultures, elevated IFN-γ reduced the mRNAs encoding for RANKL, TRAP, and Cathepsin K. Molecular imaging showed increased calcium signal intensity in stimulated versus unstimulated parts. CD14+ monocytes treated either with recombinant human IFN-γ or with conditioned media-derived IFN-γ exhibited low levels of Cathepsin K, TRAP, RANK, and tumor necrosis factor receptor-associated factor 6 mRNAs, whereas concentrations of the T-cell co-activators CD80 and CD86 increased in parallel with reduced osteoclast resorptive function, effects abrogated by neutralizing anti-IFN-γ antibodies. CD8+ cell-derived IFN-γ suppresses osteoclast function and may thus favor calcification in CAVD.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28431214      PMCID: PMC5455058          DOI: 10.1016/j.ajpath.2017.02.012

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.

Authors:  S Kotake; N Udagawa; M Hakoda; M Mogi; K Yano; E Tsuda; K Takahashi; T Furuya; S Ishiyama; K J Kim; S Saito; T Nishikawa; N Takahashi; A Togari; T Tomatsu; T Suda; N Kamatani
Journal:  Arthritis Rheum       Date:  2001-05

2.  Circulating activated and effector memory T cells are associated with calcification and clonal expansions in bicuspid and tricuspid valves of calcific aortic stenosis.

Authors:  Robert Winchester; Margrit Wiesendanger; Will O'Brien; Hui-Zhu Zhang; Mathew S Maurer; Linda D Gillam; Allan Schwartz; Charles Marboe; Allan S Stewart
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

3.  Expression of HLA-DR antigen and smooth muscle cell differentiation markers by valvular fibroblasts in degenerative aortic stenosis.

Authors:  M Olsson; M Rosenqvist; J Nilsson
Journal:  J Am Coll Cardiol       Date:  1994-12       Impact factor: 24.094

Review 4.  Molecular and cellular aspects of calcific aortic valve disease.

Authors:  Dwight A Towler
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

5.  The lymphocytic infiltration in calcific aortic stenosis predominantly consists of clonally expanded T cells.

Authors:  Henry D Wu; Mathew S Maurer; Richard A Friedman; Charles C Marboe; Elena M Ruiz-Vazquez; Rajasekhar Ramakrishnan; Allan Schwartz; M David Tilson; Allan S Stewart; Robert Winchester
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

6.  Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves.

Authors:  M Olsson; J Thyberg; J Nilsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-05       Impact factor: 8.311

7.  Osseous and chondromatous metaplasia in calcific aortic valve stenosis.

Authors:  Matthew Torre; David H Hwang; Robert F Padera; Richard N Mitchell; Paul A VanderLaan
Journal:  Cardiovasc Pathol       Date:  2015-08-29       Impact factor: 2.185

8.  Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves.

Authors:  M Olsson; C J Dalsgaard; A Haegerstrand; M Rosenqvist; L Rydén; J Nilsson
Journal:  J Am Coll Cardiol       Date:  1994-04       Impact factor: 24.094

9.  Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque.

Authors:  L Jonasson; J Holm; O Skalli; G Bondjers; G K Hansson
Journal:  Arteriosclerosis       Date:  1986 Mar-Apr

Review 10.  Osteoclasts and CD8 T cells form a negative feedback loop that contributes to homeostasis of both the skeletal and immune systems.

Authors:  Zachary S Buchwald; Rajeev Aurora
Journal:  Clin Dev Immunol       Date:  2013-06-09
View more
  18 in total

Review 1.  Recent advances in CD8+ regulatory T cell research.

Authors:  Yating Yu; Xinbo Ma; Rufei Gong; Jianmeng Zhu; Lihua Wei; Jinguang Yao
Journal:  Oncol Lett       Date:  2018-03-29       Impact factor: 2.967

2.  A Rock and a Hard Place: Chiseling Away at the Multiple Mechanisms of Aortic Stenosis.

Authors:  Elena Aikawa; Peter Libby
Journal:  Circulation       Date:  2017-05-16       Impact factor: 29.690

3.  Macrophage Heterogeneity Complicates Reversal of Calcification in Cardiovascular Tissues.

Authors:  Maximillian A Rogers; Masanori Aikawa; Elena Aikawa
Journal:  Circ Res       Date:  2017-06-23       Impact factor: 17.367

Review 4.  Innate and adaptive immunity: the understudied driving force of heart valve disease.

Authors:  Francesca Bartoli-Leonard; Jonas Zimmer; Elena Aikawa
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

5.  Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy.

Authors:  Simon Kraler; Mark C Blaser; Elena Aikawa; Giovanni G Camici; Thomas F Lüscher
Journal:  Eur Heart J       Date:  2022-02-12       Impact factor: 29.983

Review 6.  Adaptive immune cells in calcific aortic valve disease.

Authors:  Michael A Raddatz; Meena S Madhur; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-03       Impact factor: 4.733

Review 7.  Innate and adaptive immunity in cardiovascular calcification.

Authors:  Livia S A Passos; Adrien Lupieri; Dakota Becker-Greene; Elena Aikawa
Journal:  Atherosclerosis       Date:  2020-02-28       Impact factor: 5.162

Review 8.  Harnessing Single-Cell RNA Sequencing to Better Understand How Diseased Cells Behave the Way They Do in Cardiovascular Disease.

Authors:  Farwah Iqbal; Adrien Lupieri; Masanori Aikawa; Elena Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-17       Impact factor: 8.311

9.  Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets.

Authors:  Alexia Hulin; Alexandre Hego; Patrizio Lancellotti; Cécile Oury
Journal:  Front Cardiovasc Med       Date:  2018-03-14

Review 10.  Involvement of inflammatory responses in the early development of calcific aortic valve disease: lessons from statin therapy.

Authors:  Seung Hyun Lee; Jae-Hoon Choi
Journal:  Anim Cells Syst (Seoul)       Date:  2018-09-28       Impact factor: 1.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.